Is lymphopenia a predictive factor of outcomes in COVID-19 patients?
T. Znegui (tunisia, Tunisia), I. Sahnoun (tunisia, Tunisia), I. Moussa (tunisia, Tunisia), S. Ben Sassi (tunisia, Tunisia), C. Ksouri (tunisia, Tunisia), A. Allouch (tunisia, Tunisia), R. Guerfallah (tunisia, Tunisia), L. Douik El Gharbi (tunisia, Tunisia)
Source: International Congress 2022 – Biomarkers in COVID-19
Session: Biomarkers in COVID-19
Session type: Thematic Poster
Number: 871
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Znegui (tunisia, Tunisia), I. Sahnoun (tunisia, Tunisia), I. Moussa (tunisia, Tunisia), S. Ben Sassi (tunisia, Tunisia), C. Ksouri (tunisia, Tunisia), A. Allouch (tunisia, Tunisia), R. Guerfallah (tunisia, Tunisia), L. Douik El Gharbi (tunisia, Tunisia). Is lymphopenia a predictive factor of outcomes in COVID-19 patients?. 871
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|